229 related articles for article (PubMed ID: 37178737)
1. Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma.
Kumar S; Zhao J; Talluri S; Buon L; Mu S; Potluri LB; Liao C; Shi J; Chakraborty C; Gonzalez GB; Tai YT; Patel J; Pal J; Mashimo H; Samur MK; Munshi NC; Shammas MA
Gastroenterology; 2023 Aug; 165(2):357-373. PubMed ID: 37178737
[TBL] [Abstract][Full Text] [Related]
2. RAD51 Is Implicated in DNA Damage, Chemoresistance and Immune Dysregulation in Solid Tumors.
Liao C; Talluri S; Zhao J; Mu S; Kumar S; Shi J; Buon L; Munshi NC; Shammas MA
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428789
[TBL] [Abstract][Full Text] [Related]
3. Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinoma.
Kumar S; Buon L; Talluri S; Roncador M; Liao C; Zhao J; Shi J; Chakraborty C; Gonzalez G; Tai YT; Prabhala R; Samur MK; Munshi NC; Shammas MA
Commun Biol; 2021 May; 4(1):617. PubMed ID: 34031527
[TBL] [Abstract][Full Text] [Related]
4. Targeting homologous recombination and telomerase in Barrett's adenocarcinoma: impact on telomere maintenance, genomic instability and tumor growth.
Lu R; Pal J; Buon L; Nanjappa P; Shi J; Fulciniti M; Tai YT; Guo L; Yu M; Gryaznov S; Munshi NC; Shammas MA
Oncogene; 2014 Mar; 33(12):1495-505. PubMed ID: 23604115
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis.
Greene SB; Dago AE; Leitz LJ; Wang Y; Lee J; Werner SL; Gendreau S; Patel P; Jia S; Zhang L; Tucker EK; Malchiodi M; Graf RP; Dittamore R; Marrinucci D; Landers M
PLoS One; 2016; 11(11):e0165089. PubMed ID: 27851748
[TBL] [Abstract][Full Text] [Related]
6. Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers.
Watkins J; Weekes D; Shah V; Gazinska P; Joshi S; Sidhu B; Gillett C; Pinder S; Vanoli F; Jasin M; Mayrhofer M; Isaksson A; Cheang MC; Mirza H; Frankum J; Lord CJ; Ashworth A; Vinayak S; Ford JM; Telli ML; Grigoriadis A; Tutt AN
Cancer Discov; 2015 May; 5(5):488-505. PubMed ID: 25770156
[TBL] [Abstract][Full Text] [Related]
7. RAD51 Inhibitor Reverses Etoposide-Induced Genomic Toxicity and Instability in Esophageal Adenocarcinoma Cells.
Liao C; Zhao J; Kumar S; Chakraborty C; Talluri S; Munshi NC; Shammas MA
Arch Clin Toxicol (Middlet); 2020; 2(1):3-9. PubMed ID: 32968740
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of APE1 potentiates breast cancer cells to olaparib by inhibiting PARP-1 expression.
Ma X; Dang C; Min W; Diao Y; Hui W; Wang X; Dai Z; Wang X; Kang H
Breast Cancer Res Treat; 2019 Jul; 176(1):109-117. PubMed ID: 30989461
[TBL] [Abstract][Full Text] [Related]
9. miR-520g and miR-520h overcome bortezomib resistance in multiple myeloma via suppressing APE1.
Yuan X; Ma R; Yang S; Jiang L; Wang Z; Zhu Z; Li H
Cell Cycle; 2019 Jul; 18(14):1660-1669. PubMed ID: 31204563
[No Abstract] [Full Text] [Related]
10. APE1-mediated DNA damage repair provides survival advantage for esophageal adenocarcinoma cells in response to acidic bile salts.
Hong J; Chen Z; Peng D; Zaika A; Revetta F; Washington MK; Belkhiri A; El-Rifai W
Oncotarget; 2016 Mar; 7(13):16688-702. PubMed ID: 26934647
[TBL] [Abstract][Full Text] [Related]
11. Exposure of Barrett's and esophageal adenocarcinoma cells to bile acids activates EGFR-STAT3 signaling axis via induction of APE1.
Bhat AA; Lu H; Soutto M; Capobianco A; Rai P; Zaika A; El-Rifai W
Oncogene; 2018 Nov; 37(46):6011-6024. PubMed ID: 29991802
[TBL] [Abstract][Full Text] [Related]
12. APE1 Upregulates MMP-14 via Redox-Sensitive ARF6-Mediated Recycling to Promote Cell Invasion of Esophageal Adenocarcinoma.
Lu H; Bhat AA; Peng D; Chen Z; Zhu S; Hong J; Maacha S; Yan J; Robbins DJ; Washington MK; Belkhiri A; El-Rifai W
Cancer Res; 2019 Sep; 79(17):4426-4438. PubMed ID: 31308045
[TBL] [Abstract][Full Text] [Related]
13. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.
Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS
Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma.
Izzo JG; Wu TT; Wu X; Ensor J; Luthra R; Pan J; Correa A; Swisher SG; Chao CK; Hittelman WN; Ajani JA
J Clin Oncol; 2007 Feb; 25(6):698-707. PubMed ID: 17308274
[TBL] [Abstract][Full Text] [Related]
15. Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinoma.
Lockwood WW; Thu KL; Lin L; Pikor LA; Chari R; Lam WL; Beer DG
Clin Cancer Res; 2012 Apr; 18(7):1936-46. PubMed ID: 22328562
[TBL] [Abstract][Full Text] [Related]
16. Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma.
Lu H; Cao LL; Ballout F; Belkhiri A; Peng D; Chen L; Chen Z; Soutto M; Wang TC; Que J; Giordano S; Washington MK; Chen S; McDonald OG; Zaika A; El-Rifai W
Gut; 2023 Dec; 73(1):47-62. PubMed ID: 37734913
[TBL] [Abstract][Full Text] [Related]
17. Lung tumourigenesis in a conditional Cul4A transgenic mouse model.
Yang YL; Hung MS; Wang Y; Ni J; Mao JH; Hsieh D; Au A; Kumar A; Quigley D; Fang LT; Yeh CC; Xu Z; Jablons DM; You L
J Pathol; 2014 Jun; 233(2):113-23. PubMed ID: 24648314
[TBL] [Abstract][Full Text] [Related]
18. Genomic evolution in Barrett's adenocarcinoma cells: critical roles of elevated hsRAD51, homologous recombination and Alu sequences in the genome.
Pal J; Bertheau R; Buon L; Qazi A; Batchu RB; Bandyopadhyay S; Ali-Fehmi R; Beer DG; Weaver DW; Shmookler Reis RJ; Goyal RK; Huang Q; Munshi NC; Shammas MA
Oncogene; 2011 Aug; 30(33):3585-98. PubMed ID: 21423218
[TBL] [Abstract][Full Text] [Related]
19. Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis.
Nones K; Waddell N; Wayte N; Patch AM; Bailey P; Newell F; Holmes O; Fink JL; Quinn MCJ; Tang YH; Lampe G; Quek K; Loffler KA; Manning S; Idrisoglu S; Miller D; Xu Q; Waddell N; Wilson PJ; Bruxner TJC; Christ AN; Harliwong I; Nourse C; Nourbakhsh E; Anderson M; Kazakoff S; Leonard C; Wood S; Simpson PT; Reid LE; Krause L; Hussey DJ; Watson DI; Lord RV; Nancarrow D; Phillips WA; Gotley D; Smithers BM; Whiteman DC; Hayward NK; Campbell PJ; Pearson JV; Grimmond SM; Barbour AP
Nat Commun; 2014 Oct; 5():5224. PubMed ID: 25351503
[TBL] [Abstract][Full Text] [Related]
20. The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells.
Hansen SN; Ehlers NS; Zhu S; Thomsen MB; Nielsen RL; Liu D; Wang G; Hou Y; Zhang X; Xu X; Bolund L; Yang H; Wang J; Moreira J; Ditzel HJ; Brünner N; Schrohl AS; Stenvang J; Gupta R
BMC Genomics; 2016 Jun; 17():442. PubMed ID: 27277198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
